Inhibition of lysozyme by taurine dibromamine
| dc.contributor.author | Petrônio, M. S. [UNESP] | |
| dc.contributor.author | Ximenes, V. F. [UNESP] | |
| dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
| dc.date.accessioned | 2022-04-29T07:12:40Z | |
| dc.date.available | 2022-04-29T07:12:40Z | |
| dc.date.issued | 2013-11-01 | |
| dc.description.abstract | Hypobromous acid (HOBr) is a powerful oxidant produced by stimulated neutrophils and eosinophils. Taurine, a non-protein amino acid present in high amounts in the leukocytes, reacts instantaneously with HOBr leading to their haloamine derivative taurine dibromamine (Tau-NBr2). Lysozyme is a bactericidal enzyme also present in leukocytes and in secretory fluids. The inhibition of lysozyme is a pathway for bacterial proliferation in inflammatory sites. Here, we investigated the inhibition of the enzymatic activity of lysozyme when it was submitted to oxidation by Tau-NBr2. We found that the oxidation of lysozyme by Tau-NBr2 decreased its enzymatic activity in 80%, which was significant higher compared to the effect of its precursor HOBr (30%). The study and comparison of Tau-NBr2 and HOBr regarding the alterations provoked in the intrinsic fluorescence, synchronous fluorescence, resonance light scattering and near and far-UV circular dichroism spectra of lysozyme and oxidized lysozyme revealed that tryptophan residues in the active site of the protein were the main target for Tau-NBr2 and could explain its efficacy as inhibitor of lysozyme enzymatic activity. This property of Tau-NBr2 may have pathological significance, since it can be easily produced in the inflammatory sites. © 2013 Bentham Science Publishers. | en |
| dc.description.affiliation | Department of Chemistry Faculty of Sciences São Paulo State University (UNESP), 17033-360, Bauru, São Paulo | |
| dc.description.affiliation | Department of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University (UNESP), 14801-902, Araraquara, São Paulo | |
| dc.description.affiliationUnesp | Department of Chemistry Faculty of Sciences São Paulo State University (UNESP), 17033-360, Bauru, São Paulo | |
| dc.description.affiliationUnesp | Department of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University (UNESP), 14801-902, Araraquara, São Paulo | |
| dc.format.extent | 1232-1237 | |
| dc.identifier | http://dx.doi.org/10.2174/0929866511320110007 | |
| dc.identifier.citation | Protein and Peptide Letters, v. 20, n. 11, p. 1232-1237, 2013. | |
| dc.identifier.doi | 10.2174/0929866511320110007 | |
| dc.identifier.issn | 0929-8665 | |
| dc.identifier.scopus | 2-s2.0-84887939857 | |
| dc.identifier.uri | http://hdl.handle.net/11449/227314 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Protein and Peptide Letters | |
| dc.source | Scopus | |
| dc.subject | Eosinophils | |
| dc.subject | Hypobromous acid | |
| dc.subject | Hypochlorous acid | |
| dc.subject | Lysozyme | |
| dc.subject | Neutrophils | |
| dc.subject | Taurine dibromamine | |
| dc.title | Inhibition of lysozyme by taurine dibromamine | en |
| dc.type | Artigo | pt |
| dspace.entity.type | Publication | |
| relation.isDepartmentOfPublication | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
| relation.isDepartmentOfPublication | 07a200d2-8576-430b-966f-858ac732e282 | |
| relation.isDepartmentOfPublication.latestForDiscovery | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
| unesp.department | Química - FC | pt |
| unesp.department | Análises Clínicas - FCF | pt |
